Interrelationship of Tissue Factor With Thromboinflammatory Biomarkers in ESRD and CKD 5 Patients.

Authors

Luke Rohde, Fakiha Siddiqui, Katherine Konczak, Ella Kaufmann, Debra Hoppensteadt, Jeanine Walenga, Vinod Bansal, Hamzah Hussain, Jawed Fareed, Kavitha Vellanki

Published in

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. Volume 32. Pages 10760296261496960. Epub Oct 07, 2026.

Abstract

Chronic kidney disease (CKD) affects hundreds of millions worldwide and contributes to significant morbidity and mortality. Understanding its pathophysiology may help identify plasma biomarkers that reflect disease severity and treatment response. This study compared plasma tissue factor (TF) concentrations between end-stage renal disease (ESRD) patients and healthy controls using combined 2022 and 2023 retrospective cohorts (142 ESRD, 22 controls). Mean TF levels were calculated, and percent change for each ESRD patient was determined relative to the healthy control mean. In 2022, normal human plasma (NHP) TF averaged 96.37 ± 12.72 pg/mL versus 305.19 ± 11.57 pg/mL in ESRD patients, a 216.68% increase. In 2023, NHP TF was 60.19 ± 12.12 pg/mL compared with 341.93 ± 20.40 pg/mL in ESRD patients, a 468.11% increase. Across both cohorts, ESRD patients showed markedly elevated TF levels, supporting a pronounced pro-thrombotic state driven by inflammation and endothelial dysfunction from chronic uremic metabolite accumulation.

PMID:
42842756
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.